GR3035402T3 - Use of incense in the treatment of alzheimer's disease - Google Patents

Use of incense in the treatment of alzheimer's disease

Info

Publication number
GR3035402T3
GR3035402T3 GR20010400230T GR20010400230T GR3035402T3 GR 3035402 T3 GR3035402 T3 GR 3035402T3 GR 20010400230 T GR20010400230 T GR 20010400230T GR 20010400230 T GR20010400230 T GR 20010400230T GR 3035402 T3 GR3035402 T3 GR 3035402T3
Authority
GR
Greece
Prior art keywords
incense
alzheimer
disease
treatment
derivative
Prior art date
Application number
GR20010400230T
Other languages
English (en)
Inventor
Rainer Etzel
Original Assignee
Rainer Etzel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rainer Etzel filed Critical Rainer Etzel
Publication of GR3035402T3 publication Critical patent/GR3035402T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR20010400230T 1994-12-13 2001-02-12 Use of incense in the treatment of alzheimer's disease GR3035402T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4444288A DE4444288A1 (de) 1994-12-13 1994-12-13 Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
PCT/EP1995/004586 WO1996018407A1 (de) 1994-12-13 1995-11-21 Verwendung von weihrauch zur behandlung der alzheimer-krankheit

Publications (1)

Publication Number Publication Date
GR3035402T3 true GR3035402T3 (en) 2001-05-31

Family

ID=6535638

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400230T GR3035402T3 (en) 1994-12-13 2001-02-12 Use of incense in the treatment of alzheimer's disease

Country Status (15)

Country Link
US (1) US5720975A (el)
EP (1) EP0796103B1 (el)
JP (1) JPH10510276A (el)
CN (1) CN1092973C (el)
AT (1) ATE198550T1 (el)
CA (1) CA2207437A1 (el)
CZ (1) CZ288071B6 (el)
DE (2) DE4444288A1 (el)
DK (1) DK0796103T3 (el)
ES (1) ES2153906T3 (el)
GR (1) GR3035402T3 (el)
PL (1) PL320687A1 (el)
PT (1) PT796103E (el)
RU (1) RU2184562C2 (el)
WO (1) WO1996018407A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19531067A1 (de) * 1995-08-23 1997-02-27 Hermann P T Prof Dr Med Ammon Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
WO2002024173A2 (de) * 2000-09-20 2002-03-28 R.P. Scherer Gmbh & Co. Kg Orale zubereitungsformen von extrakten aus boswellia
WO2002066491A1 (en) * 2001-02-15 2002-08-29 Sabinsa Corporation Water soluble boswellic acids, their preparation and use for treating imflammatory conditions
GB0201508D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Organic compounds
CN1304007C (zh) * 2002-02-04 2007-03-14 中国医学科学院药物研究所 乙酰乳香酸在制备肿瘤转移抑制剂中的应用
WO2004082699A2 (de) * 2003-03-18 2004-09-30 Keyneurotek Ag Verwendung von weihrauch oder seinen hydrierungsprodukten zur prophylaxe und/oder behandlung von zerebraler ischämie und/oder schädel/hirntrauma
DE10331750A1 (de) * 2003-07-14 2005-02-10 Keyneurotek Ag Verwendung der Hydrierungsprodukte von Weihrauch (Olibanum) zur Prophylaxe und/oder Behandlung von zerebraler Ischämie, Schädel/Hirntrauma und/oder Alzheimer-Krankheit
CN100569245C (zh) * 2005-06-02 2009-12-16 成都中医药大学 乳香在制备治疗痛风的药物中的用途
WO2010029578A2 (en) 2008-09-15 2010-03-18 Ganga Raju Gokaraju Synergistic anti-inflammatory compositions comprising boswellia serrata extracts
WO2010105821A1 (de) 2009-03-17 2010-09-23 Herta Ertelt Verfahren zur extraktion von pflanzlichen harzen sowie dadurch gewonnene extraktionsprodukte und deren verwendung
US12005094B2 (en) 2009-07-18 2024-06-11 Compton Developments Ltd. Inhibitor of inflammatory conditions
CN104922183B (zh) * 2009-07-18 2020-04-21 康普顿发展有限公司 炎症性疾病的抑制剂
US10940175B2 (en) 2009-07-18 2021-03-09 Compton Developments Ltd. Inhibitor of inflammatory conditions
BR112012022983A2 (pt) * 2010-03-15 2015-09-15 Laila Nutraceuticals óleo de bosvélia, sua frações e composições para melhoria do funcionamento cerebral
US8828377B2 (en) * 2010-03-15 2014-09-09 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
KR101910781B1 (ko) 2010-09-07 2018-10-22 레제네라 파마 리미티드 매스틱 검의 산성 추출물을 포함하는 조성물
WO2012177825A1 (en) 2011-06-21 2012-12-27 Bvw Holding Ag Medical device comprising boswellic acid
ITPD20120343A1 (it) * 2012-11-13 2014-05-14 Matteo Bevilacqua Composto in particolare per la cura della depressione e dell'ansia
CN103393740B (zh) * 2013-07-31 2015-10-14 中国人民解放军第四军医大学 乳香提取物在防治心脑血管或肝肾损伤中应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064823A (en) * 1988-08-24 1991-11-12 Research Triangle Institute Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
CA1330944C (en) * 1988-08-24 1994-07-26 De-Hua Li Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
CN1053363A (zh) * 1990-09-11 1991-07-31 李竞 能预防和缓解痛经的香水
US5280119A (en) * 1991-11-01 1994-01-18 Boron Biologicals, Inc. Heterocyclic amine-boranes, and method of inhibiting DNA topoisomerase activity and/or combatting inflammation, hyperlipidemia, and/or neoplasia using amine-borane compounds
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
CN1033331C (zh) * 1992-11-13 1996-11-20 中国科学院长春应用化学研究所 聚芳醚砜/液晶高聚物分子复合材料及制备方法
CN1046088C (zh) * 1992-12-19 1999-11-03 管遵信 一种中药美容液及其生产方法
CN1030373C (zh) * 1993-03-27 1995-11-29 张会来 腰痹灵
US5494668A (en) * 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor

Also Published As

Publication number Publication date
EP0796103B1 (de) 2001-01-10
ES2153906T3 (es) 2001-03-16
US5720975A (en) 1998-02-24
DK0796103T3 (da) 2001-03-05
EP0796103A1 (de) 1997-09-24
RU2184562C2 (ru) 2002-07-10
PL320687A1 (en) 1997-10-27
DE4444288A1 (de) 1996-06-20
CZ288071B6 (cs) 2001-04-11
CN1092973C (zh) 2002-10-23
WO1996018407A1 (de) 1996-06-20
DE59508961D1 (de) 2001-02-15
CZ177397A3 (en) 1997-11-12
CA2207437A1 (en) 1996-06-20
PT796103E (pt) 2001-04-30
JPH10510276A (ja) 1998-10-06
CN1173134A (zh) 1998-02-11
ATE198550T1 (de) 2001-01-15

Similar Documents

Publication Publication Date Title
GR3035402T3 (en) Use of incense in the treatment of alzheimer's disease
BR0008323A (pt) Derivado de gabapentina para a prevenção e o tratamento de dor visceral
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
HUT71889A (en) Pharmaceutical compositions containing terfenadine metabolites and their optically pure isomers for treating allergic disorders
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
GB9408775D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
ES2157005T3 (es) Uso del acido boswellico y sus derivados para la inhibicion de la actividad normal y elevada de la elastasa de leucocitos o de la plasmina.
GB2285219A (en) Use of norastemizole for the treatment of allergic disorders
GR3015014T3 (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts.
CA2180178A1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
IL112288A (en) Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
DE3872881D1 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
WO2004082699A3 (de) Verwendung von weihrauch oder seinen hydrierungsprodukten zur prophylaxe und/oder behandlung von zerebraler ischämie und/oder schädel/hirntrauma
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
GR3022608T3 (en) USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE.
HUT73500A (en) Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf
HU911272D0 (en) Process for the production of medical preparations containing hexetidine
HU9502320D0 (en) Use of inhibitors of ornitine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease and process to prepare (2s,5s)-5-fluoromethylornithine
Češková et al. Alternative therapeutic approaches to the treatment of acute phases of endogenous psychoses.
MD1505F1 (en) Preparation for treatment of rheumatoid affections
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
RU99104174A (ru) Лечение психотических расстройств

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees